Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Puberty
Clinical trial NCT06926933 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06926933
- Sponsor
- HanAll BioPharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-12
- Primary completion
- 2026-06-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.